DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 258.90B KRW in the quarter ending June 30, 2026, with 10.90% growth. This brings the company's total for the last twelve months to 979.60B, up 12.73% year-over-year. In the year 2025, DongKook Pharmaceutical had annual revenue of 926.88B with 14.12% growth. That makes DongKook Pharmaceutical the 9,072nd largest company in the world by revenue and 420th in South Korea.

• Revenue (ttm): 979.60B
• Revenue Growth: +12.73%
• P/S Ratio: 1.13
• Revenue / Employee: 762.33M
• Employees: n/a
• Market Cap: 1.10T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals 897.25B 95.0%
• Cosmetics 39.00B 4.1%
• Beauty Device 8.26B 0.9%

By Geography

Chart

• South Korea 846.45B 91.3%
• Overseas 80.44B 8.7%

Fiscal year ended Dec 31, 2025 See the full DongKook Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	926.88B	114.72B	14.12%
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error